Both in Pharmaceuticals
Entrada Therapeutics vs Cartesian Therapeutics
Over the past year TRDA returned −30.4% and RNAC returned −21.2%; their daily moves had a correlation of 0.20.
TRDA −30.4% RNAC −21.2%Growth of $1, one year, split-adjusted
| Metric | TRDA | RNAC |
|---|---|---|
| Price | $4.72 | $6.41 |
| Market cap | $183.8M | $193.9M |
| Today | −7.63% | +1.10% |
| 1 month | −13.9% | −10.2% |
| 6 months | −70.0% | −13.3% |
| Year to date | −54.1% | −11.1% |
| 1 year | −32.1% | −21.5% |
| Revenue growth (YoY) | −53.9% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −4762.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 39.2× | 131.3× |
| Net cash | $223.0M | $94.8M |
| Dividend yield | — | — |
| Volatility (60d) | 84.9% | 49.0% |
| Short % of float | 13.0% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).